Upload Avatar (500 x 500)
Hongjun Li
hongjun@zju.edu.cn
Chinese, English
Zhejiang
Zhejiang University
Pharmaceutical Sciences
  • 2012-9 to 2017-6 Ph.D. in Biomaterials: University of Science and Technology of China
  • 2008-9 to 2012-6 Bachelor's in Chemistry: University of Science and Technology of China
  • Published over 70 papers in high-impact journals
  • Cited over 5000 times, with a single paper cited over 600 times
  • Applied for over 10 US/China patents
  • Guest Editor for Journal of Functional Biomaterials
  • Youth Editorial Board Member for Nano Research and Exploration
  • Member of the Nano Biotechnology Branch of the Chinese Society of Biotechnology
  • Selected for the Youth Talent Support Program of the China Association for Science and Technology
  • Selected for the Zhejiang Province Ten Thousand Talents Program
  • 2020-10 to Present - Zhejiang University - Distinguished Researcher
  • 2019-8 to 2020-9 - University of California, Los Angeles - Postdoctoral Researcher
  • 2017-7 to 2019-7 - South China University of Technology - Postdoctoral Researcher
  • Youth Talent Support Program of the China Association for Science and Technology
  • Zhejiang Province Ten Thousand Talents Program
Cell-based Drug Delivery Carriers
Bioactive Cell Delivery
Tumor Immunotherapy
  • In situ formed biomolecular vesicle augment cancer therapy, Tingxizi Liang, Yuxiang Dong, Irina Cheng, Ping Wen, Fengqin Li, Feng Liu, Qing Wu, En Ren, Peifeng Liu, Hongjun Li, Zhen Gu, 2024
  • Lyophilized lymph nodes for improved delivery of chimeric antigen receptor T cells, Jiaqi Shi, Wei Wu, Dong Chen, Ziyan Liao, Tao Sheng, Yanfang Wang, Yuejun Yao, Qing Wu, Feng Liu, Ruyi Zhou, Chaojie Zhu, Xinyuan Shen, Zhengwei Mao, Yuan Ding, Weilin Wang, Gianpietro Dotti, Jie Sun, Xiao Liang, Weijia Fang, Peng Zhao, Hongjun Li, Zhen Gu, 2024
  • Cryo-shocked tumor cells deliver CRISPR-Cas9 for lung cancer regression by synthetic lethality, Feng Liu, Minhang Xin, Huiheng Feng, Wentao Zhang, Ziyan Liao, Tao Sheng, Ping Wen, Qing Wu, Tingxizi Liang, Jiaqi Shi, Ruyi Zhou, Kaixin He, Zhen Gu, Hongjun Li, 2024
  • Lymph node-biomimetic scaffold boosts CAR-T therapy against solid tumor, Ziyan Liao, Jie Jiang, Wei Wu, Jiaqi Shi, Yanfang Wang, Yuejun Yao, Tao Sheng, Feng Liu, Wei Liu, Peng Zhao, Feifei Lv, Jie Sun, Hongjun Li, Zhen Gu, 2024
  • Fluorinated lipid nanoparticles for enhancing mRNA delivery efficiency, Huipeng Zhang, Chaoyang Meng, Xuewen Yi, Jinpeng Han, Junxia Wang, Feng Liu, Qi Ling, Hongjun Li, Zhen Gu, 2024
  • Recent advances in bacteria-based platforms for inflammatory bowel diseases treatment, Jiaoying Lu, Xinyuan Shen, Hongjun Li, Juan Du, 2024
  • Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment, Yuzhi Jin, Yangyue Huang, Hui Ren, Huanhuan Huang, Chunyu Lai, Wenjun Wang, Zhou Tong, Hangyu Zhang, Wei Wu, Chuan Liu, Xuanwen Bao, Weijia Fang, Hongjun Li, Peng Zhao, Xiaomeng Dai, 2024
  • An oral bacterial pyroptosis amplifier against malignant colon cancer, Xinyu Lou, Jinqiang Wang, Xiru Jin, Xu Wang, Bin Qin, Dongchun Liu, Xianbao Shi, Defang Ouyang, Zhonggui He, Jin Sun, Hongjun Li, Mengchi Sun, 2024
  • Rationally designed approaches to augment CAR-T therapy for solid tumor treatment, Chaojie Zhu, Qing Wu, Tao Sheng, Jiaqi Shi, Xinyuan Shen, Jicheng Yu, Yang Du, Jie Sun, Tingxizi Liang, Kaixin He, Yuan Ding, Hongjun Li, Zhen Gu, Weilin Wang, 2024
  • Inhibition of tumor metastasis by liquid nitrogen-shocked tumor cells with oncolytic viruses infection, Qing Wu, Hanwei Huang, Mengchi Sun, Ruizhe Zhang, Junxia Wang, Hanqi Zheng, Chaojie Zhu, Shihua Yang, Xinyuan Shen, Jiaqi Shi, Feng Liu, Wei Wu, Jin Sun, Funan Liu, Hongjun Li, Zhen Gu, 2023
  • Biomimetic and NOS-responsive nanomotor deeply delivery a combination of MSC-EV and mitochondrial ROS scavenger and promote heart repair and regeneration, Ning Zhang, Mengkang Fan, Yongchao Zhao, Xiaolong Hu, Qiongjun Zhu, Xiaolu Jiao, Qingbo Lv, Duanbin Li, Zheyong Huang, Guosheng Fu, Junbo Ge, Hongjun Li, Wenbin Zhang, 2023
  • Local drug delivery techniques for triggering immunogenic cell death, En Ren, Yanfang Wang, Tingxizi Liang, Hanqi Zheng, Jiaqi Shi, Zesheng Cheng, Hongjun Li, Zhen Gu, 2023
  • Non-invasive activation of intratumoural gene editing for improved adoptive T-cell therapy in solid tumours, Xiaohong Chen, Shuang Wang, Yuxuan Chen, Huhu Xin, Shuaishuai Zhang, Di Wu, Yanan Xue, Menglei Zha, Hongjun Li, Kai Li, Zhen Gu, Wei Wei, Yuan Ping, 2023
  • Metabolic reprogramming of Nk cells by black phosphorus quantum dots potentiates cancer immunotherapy, Lizhen He, Jianfu Zhao, Hongjun Li, Bin Xie, Ligeng Xu, Guanning Huang, Ting Liu, Zhen Gu, Tianfeng Chen, 2023
  • Ferric iron coordinated cisplatin prodrug reprograms the immune-cold tumor microenvironment through tumor hypoxia relief for enhanced cancer photodynamic-immunotherapy, Yinchu Ma, Yingli Luo, Xinfeng Tang, Wei Jiang, Hongjun Li, Jilong Wang, 2023
  • Engineered bacteria for augmented in situ tumor vaccinations, Xinyuan Shen, Chaojie Zhu, Xutao Liu, Hanqi Zheng, Qing Wu, Jijin Xie, Hao Huang, Ziyan Liao, Jiaqi Shi, Kewang Nan, Xuming Mao, Zhen Gu, Hongjun Li, 2023
  • Cell Delivery Devices for Cancer Immunotherapy, Ping Wen, Wei Wu, Feifan Wang, Hanqi Zheng, Ziyan Liao, Jiaqi Shi, Chaojie Zhu, Peng Zhao, Hao Cheng, Hongjun Li, Zhen Gu, 2023
  • Recent advances of bioresponsive polymeric nanomedicine for cancer therapy, Tu Hong, Xinyuan Shen, Madiha Zahra Syeda, Yang Zhang, Haonan Sheng, Yipeng Zhou, Jinming Xu, Chaojie Zhu, Hongjun Li, Zhen Gu, Longguang Tang, 2023
  • Scattered seeding of CAR T cells in solid tumors augments anticancer efficacy, Hongjun Li, Zejun Wang, Edikan Archibong, Qing Wu, Guojun Chen, Quanyin Hu, Tianyuan Ci, Zhaowei Chen, Jinqiang Wang, Di Wen, Hongwei Du, Jie Jiang, Jie Sun, Xingcai Zhang, Gianpietro Dotti, Zhen Gu, 2022
  • Bioorthogonal catalysis for biomedical applications, Tingxizi Liang, Zhaowei Chen, Hongjun Li, Zhen Gu, 2022
  • Leveraging biomaterials for enhancing T cell immunotherapy, Ziyan Liao, Wentao Zhang, Hanqi Zheng, Yanfang Wang, Jicheng Yu, Hongjun Li, Zhen Gu, 2022
  • Nanomodulators targeting tumor-resident immunosuppressive cells: mechanisms and recent updates, Xinyuan Shen, Chaojie Zhu, Qing Wu, Jiaqi Shi, Wei Wu, Xiao Zhao, Jie Sun, Hongjun Li, Zhen Gu, 2022
  • Adipocytes encapsulating telratolimod recruit and polarize tumor-associated macrophages for cancer immunotherapy, Di Wen, Tingxizi Liang, Guojun Chen, Hongjun Li, Zejun Wang, Jinqiang Wang, Ruxing Fu, Xiao Han, Tianyuan Ci, Yuqi Zhang, Peter Abdou, Ruoxing Li, Linlin Bu, Gianpietro Dotti, Zhen Gu, 2022
  • Nanohydroxyapatite stimulates pd-l1 expression to boost melanoma combination immunotherapy, Yuedi Yang, Yani Cui, Wanxu Cao, Mingda Zhao, Weimin Lin, Ruiling Xu, Yang Xu, Yafang Chen, Hongjun Li, Jie Liang, Yunfeng Lin, Yujiang Fan, Xingdong Zhang, Yong Sun, 2022
  • Integration of synthetic biology and nanobiotechnology for biomedical applications, Hanqi Zheng, Qing Wu, Hongjun Li, Zhen Gu, 2022
  • Leveraging macrophages for cancer theranostics, Lu Liu, Hongjun Li, Jinqiang Wang, Jinchao Zhang, Xing-Jie Liang, Weisheng Guo, Zhen Gu, 2022
  • Delivery strategies in treatments of leukemia, Tianyuan Ci, Wentao Zhang, Yingyu Qiao, Huangjuan Li, Jing Zang, Hongjun Li, Nianping Feng, Zhen Gu, 2022
  • Tailoring the physicochemical properties of nanomaterials for immunomodulation, Junjie Deng, Jilong Wang, Jiaqi Shi, Hongjun Li, Mingqin Lu, Zhiyuan Fan, Zhen Gu, Hao Cheng, 2022
  • Bioorthogonal catalytic patch, Zhaowei Chen, Hongjun Li, Yijie Bian, Zejun Wang, Guojun Chen, Xudong Zhang, Yimin Miao, Di Wen, Jinqiang Wang,
Drug Delivery Cell Engineering Biomedical Engineering Tumor Therapy Immunotherapy Bioactive Cells Therapeutic Platforms Precision Delivery Biomolecular Vesicles Crispr-Cas9

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.